Henry Withers

464 total citations
16 papers, 349 citations indexed

About

Henry Withers is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Henry Withers has authored 16 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Immunology. Recurrent topics in Henry Withers's work include RNA modifications and cancer (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (3 papers). Henry Withers is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (3 papers). Henry Withers collaborates with scholars based in United States, Japan and Switzerland. Henry Withers's co-authors include Christopher D. Moyes, Harold D. Love, Alaina Garbens, Simon W. Hayward, Leonardo J. Magnoni, Irwin H. Gelman, Song Liu, William T. Curry, Alan D. Hutson and Eric T. Wong and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Oncogene.

In The Last Decade

Henry Withers

12 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henry Withers United States	8	177	114	85	84	63	16	349
Tracy J. Berg United States	10	279 1.6×	125 1.1×	72 0.8×	111 1.3×	60 1.0×	15	461
Alice Boissard France	10	171 1.0×	83 0.7×	34 0.4×	74 0.9×	44 0.7×	21	301
Emilie Denicolaï France	10	135 0.8×	100 0.9×	55 0.6×	72 0.9×	128 2.0×	17	324
Cécile Henry France	10	205 1.2×	98 0.9×	63 0.7×	76 0.9×	115 1.8×	19	405
L. Francisco Lorenzo‐Martín Spain	12	278 1.6×	119 1.0×	50 0.6×	74 0.9×	25 0.4×	37	466
Aiko Murai Japan	11	301 1.7×	132 1.2×	93 1.1×	71 0.8×	22 0.3×	35	433
Ki-Chun Yoo South Korea	14	291 1.6×	199 1.7×	61 0.7×	153 1.8×	61 1.0×	20	536
Jessica L. Weatherbee United States	3	179 1.0×	76 0.7×	29 0.3×	63 0.8×	91 1.4×	4	302
Óscar Meca‐Cortés Spain	9	315 1.8×	99 0.9×	41 0.5×	110 1.3×	29 0.5×	12	416
Diane L. Trinh Canada	9	367 2.1×	132 1.2×	62 0.7×	157 1.9×	73 1.2×	15	508

Countries citing papers authored by Henry Withers

Since Specialization

Citations

This map shows the geographic impact of Henry Withers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Withers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Withers more than expected).

Fields of papers citing papers by Henry Withers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Withers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Withers. The network helps show where Henry Withers may publish in the future.

Co-authorship network of co-authors of Henry Withers

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Withers. A scholar is included among the top collaborators of Henry Withers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Withers. Henry Withers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Withers, Henry, et al.. (2025). STAG2 expression imparts distinct therapeutic vulnerabilities in muscle-invasive bladder cancer cells. Oncogenesis. 14(1). 4–4.

Withers, Henry, Junko Matsuzaki, Mark D. Long, et al.. (2025). mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors. Journal for ImmunoTherapy of Cancer. 13(3). e010408–e010408. 2 indexed citations

Commane, Mairead, et al.. (2025). Quantitative single-cell imaging suggests increased global chromatin accessibility in tumor versus non-tumor cell lines. iScience. 28(10). 113570–113570.

Ozawa, Hiroki, Yin Wang, Henry Withers, et al.. (2025). MUC1-C auto-regulatory complex with EBNA1 is responsible for latent Epstein-Barr virus-associated gastric cancer progression. Oncogene. 44(38). 3609–3624.

Dong, Bowen, Nataša Obermajer, Takemasa Tsuji, et al.. (2024). NK Receptor Signaling Lowers TCR Activation Threshold, Enhancing Selective Recognition of Cancer Cells by TAA-Specific CTLs. Cancer Immunology Research. 12(10). 1421–1437. 3 indexed citations

Halpert, Matthew M., Spencer R. Rosario, Henry Withers, et al.. (2024). Multifactoral immune modulation potentiates durable remission in multiple models of aggressive malignancy. The FASEB Journal. 38(10). e23644–e23644.

Yamashita, Nami, Henry Withers, Yoshihiro Morimoto, et al.. (2023). MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells. iScience. 26(11). 108168–108168. 7 indexed citations

Yamashita, Nami, Yoshihiro Morimoto, Atsushi Fushimi, et al.. (2022). MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer. Molecular Cancer Research. 21(3). 274–289. 25 indexed citations

Fushimi, Atsushi, Yoshihiro Morimoto, Satoshi Ishikawa, et al.. (2022). Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non–neuroendocrine Small Cell Lung Cancer. Molecular Cancer Research. 20(9). 1379–1390. 12 indexed citations

10.

Ciesielski, Michael J., Manmeet S. Ahluwalia, David A. Reardon, et al.. (2022). Final data from the phase 2a single-arm trial of SurVaxM for newly diagnosed glioblastoma.. Journal of Clinical Oncology. 40(16_suppl). 2037–2037. 6 indexed citations

11.

Ahluwalia, Manmeet S., David A. Reardon, William T. Curry, et al.. (2022). Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma. Journal of Clinical Oncology. 41(7). 1453–1465. 105 indexed citations

12.

Withers, Henry, et al.. (2019). Identification of Genes Regulating Breast Cancer Dormancy in 3D Bone Endosteal Niche Cultures. Molecular Cancer Research. 17(4). 860–869. 26 indexed citations

13.

Zhang, Yinglong, He Shen, Henry Withers, et al.. (2017). VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer. Scientific Reports. 7(1). 6190–6190. 48 indexed citations

14.

Withers, Henry & Irwin H. Gelman. (2017). Abstract LB-148: Characterization of an off-target RNAi genomic screen hit identifies GPRC6A as a novel suppressor of metastatic chemotaxis and invasiveness. Cancer Research. 77(13_Supplement). LB–148. 1 indexed citations

15.

Withers, Henry, Alaina Garbens, Harold D. Love, et al.. (2009). Hypoxia and the metabolic phenotype of prostate cancer cells. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1787(12). 1433–1443. 87 indexed citations

16.

Tao, Zhimin, Henry Withers, Harvey S. Penefsky, Jerry Goodisman, & Abdul-Kader Souid. (2006). Inhibition of Cellular Respiration by Doxorubicin. Chemical Research in Toxicology. 19(8). 1051–1058. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact